MedTrace Logo

Intracranial PrEssure Time dOse (ImPETO)

NCT04459806 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2025-09-15

No results posted yet for this study

Summary

The new Integra CereLink ICP monitor integrate the possibility of recording and displaying continuously the AUC (Pressure Time Dose, PTD) and other ICP derived variables and provide the possibility of evaluating the utility of this information at the bedside. It offers the opportunity to test in a standardized way the clinical value of the PTD computation in this setting.

Therefore, this study aims to test clinically if PTD recorded continuously is associated to patients' outcome and to identify a threshold of PTD associated with the transition from good to negative outcomes.

Conditions

Interventions

PROCEDURE

intracranial pressure monitoring

Invasive monitoring of intracranial pressure by using CereLink monitor.

Sponsors & Collaborators

  • Integra LifeSciences Corporation

    collaborator INDUSTRY

  • University of Milano Bicocca

    lead OTHER

Principal Investigators

  • Giuseppe Citerio, Professor · University of Milano Bicocca

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-13
Primary Completion
2026-11-30
Completion
2026-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04459806 on ClinicalTrials.gov